HighTower Advisors LLC raised its holdings in McKesson Corporation (NYSE:MCK - Free Report) by 51.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 128,991 shares of the company's stock after acquiring an additional 43,993 shares during the period. HighTower Advisors LLC owned about 0.11% of McKesson worth $110,134,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Nvwm LLC boosted its stake in shares of McKesson by 933.3% in the 3rd quarter. Nvwm LLC now owns 31 shares of the company's stock valued at $26,000 after purchasing an additional 28 shares in the last quarter. Delos Wealth Advisors LLC acquired a new position in McKesson during the 2nd quarter worth approximately $27,000. Trellis Wealth Advisors LLC acquired a new position in McKesson during the 3rd quarter worth approximately $32,000. GK Wealth Management LLC acquired a new position in McKesson during the 3rd quarter worth approximately $38,000. Finally, Curry Webb Wealth Management LLC acquired a new position in McKesson during the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 85.07% of the company's stock.
McKesson Stock Down 1.5%
Shares of NYSE:MCK opened at $1,088.68 on Wednesday. The firm has a market cap of $125.70 billion, a P/E ratio of 27.99, a P/E/G ratio of 1.87 and a beta of 0.27. McKesson Corporation has a 12-month low of $723.68 and a 12-month high of $1,121.50. The business has a fifty day simple moving average of $963.44 and a 200 day simple moving average of $877.27.
McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, beating analysts' consensus estimates of $10.72 by $0.96. The firm had revenue of $110.96 billion for the quarter, compared to analyst estimates of $109.90 billion. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. The business's revenue was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $9.86 EPS. As a group, equities research analysts expect that McKesson Corporation will post 46.16 EPS for the current year.
McKesson Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be paid a $0.94 dividend. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, December 1st. McKesson's payout ratio is currently 9.67%.
Wall Street Analysts Forecast Growth
MCK has been the subject of several research reports. Wall Street Zen raised shares of McKesson from a "hold" rating to a "buy" rating in a research note on Saturday, October 17th. Citigroup boosted their target price on shares of McKesson from $945.00 to $1,000.00 and gave the stock a "buy" rating in a research note on Friday, July 24th. Mizuho upped their price target on shares of McKesson from $905.00 to $1,020.00 and gave the stock a "neutral" rating in a report on Tuesday, October 20th. JPMorgan Chase & Co. increased their price target on McKesson from $1,042.00 to $1,255.00 and gave the company an "overweight" rating in a research note on Tuesday, November 10th. Finally, Bank of America increased their price target on McKesson from $950.00 to $1,050.00 in a research note on Thursday, August 6th. Fifteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat, McKesson has an average rating of "Moderate Buy" and an average price target of $1,040.29.
Get Our Latest Analysis on McKesson
Insider Buying and Selling
In related news, CAO B Jr sold 111 shares of the company's stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total value of $98,950.95. Following the sale, the chief accounting officer directly owned 521 shares in the company, valued at $464,445.45. This represents a 17.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 800 shares of the stock in a transaction that occurred on Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the sale, the executive vice president directly owned 5,423 shares of the company's stock, valued at $5,400,223.40. This represents a 12.86% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 2,161 shares of company stock worth $2,242,515. 0.06% of the stock is owned by insiders.
McKesson Company Profile
(
Free Report)
McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider McKesson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.
While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.